Newly-released Pediatric Home Healthcare Market analysis report by Future Market Insights reveals that global sales of the Pediatric Home Healthcare Market in 2022 were held at US$ 37.9 Billion. With a CAGR of 16.3% from 2023 to 2033, the market is projected to reach a valuation of US$ 197 Billion by 2033. Rehabilitation Therapy Services are expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 15% from 2023 to 2033.
Attribute | Details |
---|---|
Global Pediatric Home Healthcare Market (2023) | US$ 38 Billion |
Global Pediatric Home Healthcare Market (2033) | US$ 197 Billion |
Global Pediatric Home Healthcare Market CAGR (2023 to 2033) | 16.3% |
USA Pediatric Home Healthcare Market CAGR (2023 to 2033) | 17.8% |
Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Pediatric Home Healthcare Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value increased at around 15.2% CAGR.
The market is being driven by an increase in the number of children who require special care, increased awareness of residential healthcare, technological developments, and rising disposable income. The advancement of medical intervention methods has resulted in an increase in neonatal life expectancy.
The rising frequency of chronic conditions in children, such as cerebral palsy, congenital heart disease, cystic fibrosis, muscular dystrophy, cancer, and epilepsy, has allowed key businesses to enter the pediatric home healthcare sector. Furthermore, the parents’ growing inclination towards preventive measures and avoiding hospitalizations, has been leading to their increased inclination to pediatric home healthcare services. Besides, the companies have also been broadening their service provisions to offer both short and long-term home care services.
One of the primary factors in the worldwide market's growth is the growing frequency of preterm births throughout the world. Nearly 15 million preterm infants are born each year throughout the world. Long-term intellectual and developmental abnormalities, as well as difficulties with the lungs, brain, heart, and eyes, have been linked to these kids. They need the highest level of care, which will include ongoing medical treatment with the help of pediatric care at home.
During the projected period, the market for Pediatric home healthcare in Asia Pacific is predicted to develop at a healthy rate. Premature newborns and neonatal babies have a better chance of surviving in developing nations thanks to developments in medical technology; yet, these babies are at a higher risk of developing physical and neurological abnormalities, necessitating in-home Pediatric care. As a result, BAYADA Home Health Care has expanded into India, South Korea, and New Zealand.
Factors such as the rising number of preterm babies born every year and the increased frequency of several cardiac, congenital neurological, and respiratory diseases throughout the world are driving the global market. During the projected period, the market is likely to develop due to advancements in technology and growing public awareness of pediatric house care.
Based on statistics from the National Institute of Health, every year, around 8,000 to 12,000 infants with cerebral palsy are born in the United States. Congenital heart disease is one the most ubiquitous congenital ailment which is affecting 0.8% to 1.2% of all live births worldwide, with an incidence rate of roughly 1% in the United States. These factors are leading to market growth.
Because of rising awareness of home-based pediatric medical services, increased spending on pediatric healthcare, and the surge in modern practices, North America dominated the global market in 2022. The market in the region is forecasted to grow at a CAGR of 17.7% during the forecast period.
The market in the Asia Pacific is being driven due to a significant increase in the survival rate of neonates and premature infants. Premature babies are likely to have neurological and physical issues, which demand in-home pediatric care.
The United States is expected to have the highest market accounting for US$ 66.6 Billion by the end of 2033. Favorable payment rules in the United States, where Medicaid covers the bulk of pediatric care services, are propelling the industry forward. Due to an increase in the number of complicated illnesses in babies in the United States, long-term morbidity from multiple chronic diseases following preterm delivery has decreased significantly. As a result, there has been a surge in demand for pediatric home healthcare.
The market in the UK is expected to reach a valuation of US$ 9.2 Billion by 2033, growing at a CAR of 16.3% from 2023 to 2033. The market during the forecast period is expected to witness an absolute dollar opportunity of US$ 7.2 Billion.
In Japan, the market is projected to upscale at a CAGR of 17.3% from 2023 to 2033, reaching a valuation of US$ 8.4 Billion by 2033. During the forecast period, the market is expected to witness an absolute dollar opportunity of US$ 6.7 Billion.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Rehabilitation Therapy Services segment is forecasted to grow at the highest CAGR of over 15% from 2023 to 2033. Due to the increased risk of preterm neonates suffering from muscular and neurological impairments, the rehabilitation therapy services sector led the market and produced the highest revenue in 2022. Furthermore, several rehabilitation service providers for the pediatric population, such as occupational therapy, speech therapy, and physical therapy, account for a substantial share of the market for pediatric house healthcare.
During the projected period, the skilled nursing services segment is expected to increase at a rapid pace. Children with complex medical conditions such as cerebral palsy, cystic fibrosis, asthma, and epilepsy require these services. These services have significantly reduced the costs of inpatient care for children, due to which the market for services is steadily expanding.
Key companies in the pediatric home healthcare market are substantially investing in the development of innovative technologies to treat children's developmental and intellectual issues. To boost their market penetration, companies are adopting strategies such as collaborations, partnerships, raising financing, and acquisitions. The companies are also focusing on expanding their presence to go near their customers.
Some of the recent developments of key pediatric home healthcare providers are as follows:
Similarly, the team at Future Market Insights has tracked recent developments related to the companies in Pediatric Home Healthcare Market, which are available in the full report.
The pediatric home healthcare market is worth US$ 38 billion in 2023.
The pediatric home healthcare market is predicted to rise at a 16.3% CAGR through 2033.
The pediatric home healthcare market is estimated to be worth US$ 197 billion by 2033.
The rehabilitation therapy services segment leads the pediatric home healthcare market with a projected CAGR of 15% through 2033.
North America holds prominence, with a projected CAGR of 17.7% through 2033.
1. Executive Summary | Pediatric Home Healthcare Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Specialty
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Specialty, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Specialty, 2023 to 2033
5.3.1. Skilled Nursing Services
5.3.2. Personal Care Assistance
5.3.3. Rehabilitation Therapy Services
5.4. Y-o-Y Growth Trend Analysis By Specialty, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Specialty, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
6.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
7.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
7.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
7.2.1. By Country
7.2.1.1. USA
7.2.1.2. Canada
7.2.2. By Specialty
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Specialty
7.4. Key Takeaways
8. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By Specialty
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Specialty
8.4. Key Takeaways
9. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. UK
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By Specialty
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Specialty
9.4. Key Takeaways
10. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By Specialty
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Specialty
10.4. Key Takeaways
11. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of MEA
11.2.2. By Specialty
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Specialty
11.4. Key Takeaways
12. Key Countries Market Analysis
12.1. USA
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2022
12.1.2.1. By Specialty
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2022
12.2.2.1. By Specialty
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2022
12.3.2.1. By Specialty
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2022
12.4.2.1. By Specialty
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2022
12.5.2.1. By Specialty
12.6. UK
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2022
12.6.2.1. By Specialty
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2022
12.7.2.1. By Specialty
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2022
12.8.2.1. By Specialty
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2022
12.9.2.1. By Specialty
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2022
12.10.2.1. By Specialty
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2022
12.11.2.1. By Specialty
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2022
12.12.2.1. By Specialty
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2022
12.13.2.1. By Specialty
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2022
12.14.2.1. By Specialty
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2022
12.15.2.1. By Specialty
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2022
12.16.2.1. By Specialty
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2022
12.17.2.1. By Specialty
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2022
12.18.2.1. By Specialty
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2022
12.19.2.1. By Specialty
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By Specialty
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. Aveanna Healthcare, Inc.
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.2. DJK Home Healthcare LLC
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.3. BAYADA Home Health Care
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.4. Tendercare Home Health
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.5. BrightStar Care
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.6. Angels of Care Pediatric Home Health
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.7. New England Home Care, Inc.
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.8. Pediatric Home Healthcare
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.9. Enviva Paediatric Care
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.10. Interim Healthcare Inc.
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
14.1.11. eKidzCare
14.1.11.1. Overview
14.1.11.2. Product Portfolio
14.1.11.3. Profitability by Market Segments
14.1.11.4. Sales Footprint
14.1.11.5. Strategy Overview
14.1.11.5.1. Marketing Strategy
14.1.12. MGA Homecare
14.1.12.1. Overview
14.1.12.2. Product Portfolio
14.1.12.3. Profitability by Market Segments
14.1.12.4. Sales Footprint
14.1.12.5. Strategy Overview
14.1.12.5.1. Marketing Strategy
14.1.13. At Home Healthcare
14.1.13.1. Overview
14.1.13.2. Product Portfolio
14.1.13.3. Profitability by Market Segments
14.1.13.4. Sales Footprint
14.1.13.5. Strategy Overview
14.1.13.5.1. Marketing Strategy
14.1.14. ParaMed
14.1.14.1. Overview
14.1.14.2. Product Portfolio
14.1.14.3. Profitability by Market Segments
14.1.14.4. Sales Footprint
14.1.14.5. Strategy Overview
14.1.14.5.1. Marketing Strategy
15. Assumptions & Acronyms Used
16. Research Methodology
Explore Healthcare Insights
View Reports